August 2026
The global biologics market was valued at USD 487 billion in 2025 and is expected to hit around USD 1243.80 billion by 2035, growing at a CAGR of 9.83%.
March 2026
The global biologics and biosimilars market size is estimated to hit around USD 2,426.85 billion by 2035 increasing from USD 610.41 billion in 2025, with a CAGR of 14.80%.
February 2026
The global biologics CDMO market size was valued at USD 23.08 billion in 2025 and is projected to hit around USD 55.11 billion by 2035 with a healthy CAGR of 9.14%.
August 2025
The global biologics contract development market size reached USD 8.18 billion in 2024 and is projected to hit around USD 23.01 billion by 2034 with a solid CAGR of 10.89%.
September 2026
The wound care biologics market size is expected to surpass around USD 11.22 billion by 2034, increasing from USD 6.65 billion in 2026, with a CAGR of 6.75%
September 2026
The U.S. biologics market was worth USD 223.60 billion in 2026, with key U.S. biologics market players including Eli Lilly & Company, Samsung Biologics, F Hoffman La Roche.
July 2026
The orthobiologics market size was estimated at USD 7.37 billion in 2025 and is expected to surge around USD 12.55 billion by 2035, with a notable CAGR of 5.47%.
June 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
March 2026
The global cancer biologics market size was valued at USD 117.45 billion in 2025 and is expected to hit around USD 235.81 billion by 2035 with a CAGR of 7.22%.
July 2025
The anti-Inflammatory biologics market size reached USD 104.81 billion in 2024 and is projected to surpass around USD 185.51 billion by 2034 with a notable CAGR of 5.88%.
July 2025
The global next-generation biologics market size was evaluated at USD 110.58 billion in 2024 and is predicted to hit around USD 301.22 billion by 2034, growing at a CAGR of 10.54% from 2025 to 2034.
July 2025
The global chemotherapy market size was evaluated at USD 9.53 billion in 2024 and is projected to worth around USD 19.69 billion by 2034 with a CAGR of 7.53%.
July 2025
The biological safety testing market size was evaluated at USD 4.85 billion in 2024 and is predicted to surpass around USD 17.00 billion by 2034, with a CAGR of 13.36%.
July 2025
The parenteral packaging market size is estimated to surpass around USD 60.89 billion by 2034 increasing from USD 33.93 billion in 2024, growing at a CAGR of 6.02%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com